ArticleJournal of clinical medicine2025

Predictors of Super-Responder Status to Anti-IL-23 Therapies in Moderate-to-Severe Plaque Psoriasis: A Real-World Monocenter Study.

Sara Di Giulio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.